Jolanta Grembecka

Biochemistry, Genetics and Molecular Biology · University of Michigan

Established · publishing since 1997Rising activity

Protein Degradation and Inhibitors Acute Myeloid Leukemia Research Epigenetics and DNA Methylation Ubiquitin and proteasome pathways Peptidase Inhibition and Analysis

Publications

260

Citations

6,269

Est. group size

~19

Recurring co-author estimate

Active years

Publishing since 1997

In context

Among 1,668 established Biochemistry, Genetics and Molecular Biology PIs within our index

Citations: 6,269cohort median 3,422

Publications / year (recent): 19.8cohort median 4.8

Typically publishes in teams of ~10 · 18% small-team papers (≤3 authors) · across 8 venues

Publication cadence

Publications per year over the last 10 years — averaging 19.8/year recently

Collaborators per year

Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.

Recent publications

Abstract IA002: Targeted menin inhibition to disrupt leukemia fusion oncoproteins: from discovery to therapeutic applications
Cancer Research · 2026
SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylation
Genome biology · 2025
Abstract IA023: Targeting epigenetic complexes in leukemia
Molecular Cancer Therapeutics · 2024
CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex
Leukemia · 2019
Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia
Experimental Hematology · 2018
CEBPA-Mutant Acute Myeloid Leukemia is Sensitive to Small-Molecule-Mediated Inhibition of the Menin-MLL Interaction
Experimental Hematology · 2018
CEBPA-mutant acute myeloid leukemia is sensitive to small-molecule-mediated inhibition of the Menin-MLL interaction
2018
A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells
Leukemia & lymphoma/Leukemia and lymphoma · 2017
Corrigendum to: “Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers” [EBioMedicine 8 (2016) 117–131]
EBioMedicine · 2017
Menin-MLL Inhibitor MI-503 Suppresses Plasma Gastrin in a Mouse Model of Hypergastrinemia
Gastroenterology · 2017
Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers
EBioMedicine · 2016

Publishes in

Cancer Research×16
Journal of Medicinal Chemistry×5
Nature Communications×3
European Journal of Medicinal Chemistry×3
Molecular Cancer Therapeutics×3

Similar researchers

By research-topic overlap

Tomasz Cierpicki
Biochemistry, Genetics and Molecular Biology · University of Michigan
Hongzhi Miao
Biochemistry, Genetics and Molecular Biology · University of Michigan
Trupta Purohit
Biochemistry, Genetics and Molecular Biology · University of Michigan
Brittany Sandoval
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Katarzyna Kempińska
Biochemistry, Genetics and Molecular Biology · University of Michigan

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 25, 2026.

Claim or correct this profile